Pediatric Vitiligo Bangkok: English-Speaking Pediatric Dermatologist + JAK Inhibitor Treatment

Pediatric vitiligo affects 0.5-1% of children globally, with onset before age 12 in 50% of all vitiligo cases. At Siam Dermatology in Bangkok, our English-speaking specialist pediatric dermatologists — trained at the Institute of Dermatology (IOD) — manage pediatric vitiligo with internationally-aligned protocols: from autoimmune comorbidity screening to JAK inhibitor therapy (Opzelura/Ruxolitinib FDA-approved ≥12 years).

Segmental vs Non-segmental in Children

Segmental vitiligo (SV): More common in children than adults (30-40% of pediatric cases vs 5-10% adult). Unilateral, dermatomal distribution. Rapid onset over months, then stable. Lower autoimmune comorbidity. Better response to surgical melanocyte transplant. Non-segmental vitiligo (NSV): Bilateral, symmetric. Progressive course with flares. Higher autoimmune comorbidity (thyroid 20-30%, T1DM, alopecia areata, pernicious anemia). Includes generalized, acrofacial, mucosal, universal subtypes. Family history positive 20-30%.

Autoimmune Screen + Topical Therapy

Mandatory baseline workup: TSH + anti-TPO antibodies (q1-2 yr screening), fasting glucose/HbA1c (T1DM screen), ANA (screen for connective tissue disease overlap), CBC + B12 (pernicious anemia). Topical first-line: Topical tacrolimus 0.1% ointment BID — age 2-15 use 0.03% (safer pediatric), face/neck excellent response 60-75% repigmentation in 6 mo. No skin atrophy (advantage over steroids). Topical corticosteroid (Mometasone 0.1% / Fluticasone): use limited duration 8-12 weeks, avoid face. Combination tacrolimus + NB-UVB synergistic.

NB-UVB + JAK Inhibitor + Surgery

NB-UVB (311 nm narrowband UVB): Safe age ≥6 yr in most protocols. 2-3 sessions/week, 30-50% repigmentation in 6 months for face/trunk (extremities poorer response). Targeted excimer 308 nm for limited disease. Opzelura (Ruxolitinib 1.5% cream) — JAK1/2 inhibitor: FDA approved ≥12 yr non-segmental vitiligo (May 2022, expanded pediatric June 2023). Apply BID, results 24-52 weeks. F-VASI50 response 30% at 24w. Reversible if stopped — maintenance ongoing. Surgical: melanocyte/keratinocyte transplant for stable SV ≥12 yr at major centers. Camouflage: Dermablend, Cover FX for school-age, family education + pediatric psychology support critical.

FAQ

Q1: At what age can my child start treatment? A: Topical tacrolimus from age 2, NB-UVB ≥6 yr, Opzelura ≥12 yr per FDA. Q2: Will the white patches spread? A: Non-segmental typically progresses without treatment — early intervention slows or halts. Segmental usually stabilizes 6-12 months. Q3: Is Opzelura available in Thailand? A: Available via medical importation — our clinic can assist with prescription and sourcing. Approximate cost 50,000-70,000 THB/month. Q4: Does my child need blood tests? A: Yes — thyroid antibodies + diabetes screen at diagnosis, then yearly. 20-30% develop comorbid autoimmune disease.

📞 Book at Siam Dermatology — LINE @dr.patskinclinic | Call +66 61 448 7000